Evidence map›Paper›PMID 36294292›Full record

ArticleInternational journal of environmental research and public health2022

Patient Acceptability of Home Monitoring for Neovascular Age-Related Macular Degeneration Reactivation: A Qualitative Study.

Seán R O'Connor, Charlene Treanor, Elizabeth Ward, Robin A Wickens, Abby O'Connell, Lucy A Culliford, Chris A Rogers, Eleanor A Gidman, Tunde Peto, Paul C Knox and 7 more

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Seán R O'ConnorSchool of Psychology, Queen's University of Belfast, Belfast BT7 1NN, UK.ORCID 0000-0001-6805-8899
Charlene TreanorCentre for Public Health, Queen's University of Belfast, Belfast BT12 6BA, UK.
Elizabeth WardBristol Trials Centre (CTEU), University of Bristol, Bristol Royal Infirmary, Bristol BS2 8HW, UK.
Robin A WickensBristol Trials Centre (CTEU), University of Bristol, Bristol Royal Infirmary, Bristol BS2 8HW, UK.ORCID 0000-0003-4374-3747
Abby O'ConnellExeter Clinical Trials Unit (EXECTU), University of Exeter, St. Lukes Campus, Exeter EX1 2LT, UK.ORCID 0000-0001-7598-927X
Lucy A CullifordBristol Trials Centre (CTEU), University of Bristol, Bristol Royal Infirmary, Bristol BS2 8HW, UK.
Chris A RogersBristol Trials Centre (CTEU), University of Bristol, Bristol Royal Infirmary, Bristol BS2 8HW, UK.
Eleanor A GidmanBristol Trials Centre (CTEU), University of Bristol, Bristol Royal Infirmary, Bristol BS2 8HW, UK.
Tunde PetoCentre for Public Health, Queen's University of Belfast, Belfast BT12 6BA, UK.ORCID 0000-0001-6265-0381
Paul C KnoxDepartment of Eye and Vision Science, University of Liverpool, Liverpool L7 8TX, UK.
Benjamin J L BurtonJames Paget University Hospitals NHS Foundation Trust, Norfolk NR31 6LA, UK.ORCID 0000-0001-9579-9078
Andrew J LoteryDepartment of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK.ORCID 0000-0001-5541-4305
Sobha SivaprasadNIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK.ORCID 0000-0001-8952-0659
Barnaby C ReevesBristol Trials Centre (CTEU), University of Bristol, Bristol Royal Infirmary, Bristol BS2 8HW, UK.ORCID 0000-0002-5101-9487
Ruth E HoggCentre for Public Health, Queen's University of Belfast, Belfast BT12 6BA, UK.
Michael DonnellyCentre for Public Health, Queen's University of Belfast, Belfast BT12 6BA, UK.
Monarch Study Group

Funding

National Institute of Health Research 15/97/02
6 · The paper itself

Abstract

Neovascular age-related macular degeneration (nAMD) is a chronic, progressive condition and the commonest cause of visual disability in older adults. This study formed part of a diagnostic test accuracy study to quantify the ability of three index home monitoring (HM) tests (one paper-based and two digital tests) to identify reactivation in nAMD. The aim of this qualitative research was to investigate patients' or participants' views about acceptability and explore adherence to weekly HM. Semi-structured interviews were held with 78/297 participants (26%), with close family members (n = 11) and with healthcare professionals involved in training participants in HM procedures (n = 9) (n = 98 in total). A directed thematic analytical approach was applied to the data using a deductive and inductive coding framework informed by theories of technology acceptance. Five themes emerged related to: 1. The role of HM; 2. Suitability of procedures and instruments; 3. Experience of HM; 4. Feasibility of HM in usual practice; and 5. Impediments to patient acceptability of HM. Various factors influenced acceptability including a patient's understanding about the purpose of monitoring. While initial training and ongoing support were regarded as essential for overcoming unfamiliarity with use of digital technology, patients viewed HM as relatively straightforward and non-burdensome. There is a need for further research about how use of performance feedback, level of support and nature of tailoring might facilitate further the implementation of routinely conducted HM. Home monitoring was acceptable to patients and they recognised its potential to reduce clinic visits during non-active treatment phases. Findings have implications for implementation of digital HM in the care of older people with nAMD and other long-term conditions.

Indexed as

Health PersonnelMacular DegenerationAgedHumansQualitative Researchophthalmic carepatient perspectivequalitative methodstechnology acceptance

Identifiers

PMID36294292
PMCPMC9603709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.